Things are starting to look up in the world of small-cap health companies with 78 gaining ground, 23 flatlining, and 23 losing it.

 

Here’s a table showing how ASX-listed healthcare stocks have been performing.

CODE COMPANY PRICE 1 WEEK RETURN % 1 MONTH RETURN % 6 MONTH RETURN % 1 YEAR RETURN % MARKET CAP
RHT Resonance Health 0.175 67% 59% -3% -22% $69,127,797.15
LDX Lumos Diagnostics 1.06 51% 18% -15% 0% $156,570,193.52
AT1 Atomo Diagnostics 0.28 33% 44% 40% -10% $120,563,649.42
LBT LBT Innovations 0.12 32% 32% 46% 4% $36,788,677.56
IRX Inhalerx Limited 0.105 31% 12% -5% 38% $16,509,761.79
ADO Anteotech Ltd 0.285 30% 50% 10% 171% $542,862,207.80
IHL Incannex Healthcare 0.69 25% 30% 171% 360% $845,969,602.10
ACW Actinogen Medical 0.17 24% 31% 31% 710% $310,598,154.13
CDX Cardiex Limited 0.071 22% 42% -9% 13% $79,129,621.15
FFC Farmaforce Ltd 0.054 17% 17% -19% -39% $6,795,410.96
CYP Cynata Therapeutics 0.56 17% 11% 5% -19% $84,533,190.46
AHK Ark Mines Limited 0.22 16% 547% 547% 547% $6,988,523.18
GSS Genetic Signatures 1.695 15% 31% 41% -16% $250,418,430.50
RGS Regeneus Ltd 0.087 13% 21% 14% -21% $25,740,700.78
EYE Nova EYE Medical Ltd 0.35 13% 9% 11% -3% $52,399,364.76
PTX Prescient Ltd 0.245 11% 14% 7% 266% $162,523,301.25
OSX Osteopore Limited 0.245 11% 11% -48% -52% $27,558,035.93
PAB Patrys Limited 0.04 11% 8% -21% 67% $82,268,900.36
PAA Pharmaust Limited 0.105 11% 12% 11% -5% $31,691,238.30
NOX Noxopharm Limited 0.42 11% -1% -40% -11% $119,817,559.50
MEB Medibio Limited 0.0055 10% -21% -35% -39% $12,366,306.74
IIQ Inoviq Ltd 1.26 10% 15% -35% 91% $114,563,283.99
CU6 Clarity Pharma 0.82 9% -7% 0% 0% $131,985,856.84
OSL Oncosil Medical 0.047 9% 12% -31% -61% $38,032,478.11
ADR Adherium Ltd 0.012 9% 9% -33% -57% $24,240,364.95
BOT Botanix Pharma Ltd 0.06 9% 9% -35% -52% $56,442,240.29
UBI Universal Biosensors 0.98 9% 11% 3% 109% $176,939,361.48
CPH Creso Pharma Ltd 0.087 9% -5% -36% -50% $99,336,006.21
TD1 Tali Digital Limited 0.0195 8% -3% -39% -59% $18,172,162.89
MDR Medadvisor Limited 0.39 8% 3% 30% 8% $147,371,586.18
IBX Imagion Biosys Ltd 0.078 8% -1% -21% -44% $89,681,482.72
RNO Rhinomed Ltd 0.2975 8% 3% 98% 75% $75,344,648.28
DXB Dimerix Ltd 0.265 8% 10% 33% 13% $86,635,889.82
PGC Paragon Care Limited 0.3725 8% 24% 24% 66% $133,532,265.62
NSB Neuroscientific 0.35 8% 4% 8% 35% $50,932,433.27
PXS Pharmaxis Ltd 0.1125 7% 10% 29% 21% $65,870,779.56
TRU Truscreen 0.075 7% 7% 9% 0% $29,029,300.24
RSH Respiri Limited 0.062 7% 2% -16% -50% $44,816,128.98
RAD Radiopharm 0.39 7% 13% 0% 0% $44,333,453.92
RAD Radiopharm 0.39 7% 13% 0% 0% $44,333,453.92
BIT Biotron Limited 0.099 6% 15% 62% 22% $68,789,405.87
TLX Telix Pharmaceutical 8.37 6% 30% 44% 109% $2,343,299,303.76
KZA Kazia Therapeutics 1.22 6% -15% -8% 3% $166,366,883.34
ILA Island Pharma 0.27 6% -7% -4% 0% $11,675,654.82
SOM SomnoMed Limited 2.35 6% 1% -3% 9% $194,484,390.25
CGS Cogstate Ltd 2.59 6% 11% 79% 137% $442,004,244.90
MXC Mgc Pharmaceuticals 0.04 5% 0% 0% 67% $102,545,622.30
DVL Dorsavi Ltd 0.02 5% -5% -35% -51% $7,431,506.99
VTI Vision Tech Inc 0.93 5% 5% -33% -61% $20,562,885.00
ANP Antisense Therapeut. 0.21 5% 8% -5% 50% $137,084,884.37
RAP Resapp Health Ltd 0.063 5% 5% 40% -24% $55,847,810.01
IVX Invion Ltd 0.022 5% 29% 47% 110% $147,579,813.81
NYR Nyrada Inc. 0.24 4% 9% -30% -2% $28,882,169.05
PSQ Pacific Smiles Grp 2.91 4% 7% 5% 12% $469,170,897.72
CMP Compumedics Limited 0.4 4% 19% 1% -16% $69,979,364.46
NEU Neuren Pharmaceut. 3.77 4% 113% 129% 193% $491,266,136.40
CBL Control Bionics 0.43 4% -19% -36% -53% $21,390,635.05
DOC Doctor Care Anywhere 0.585 4% 14% -35% -53% $115,074,894.39
MDC Medlab Clinical Ltd 0.15 3% 0% -9% -41% $47,904,593.94
CTE Cryosite Limited 0.46 3% 31% 18% 16% $22,452,398.98
NXS Next Science Limited 1.27 3% 2% -18% 5% $245,487,647.16
ZLD Zelira Therapeutics 0.032 3% -11% -35% -64% $40,839,412.54
4DX 4Dmedical Limited 1.31 3% 5% 4% -46% $274,776,828.35
PBP Probiotec Limited 2.32 3% 5% 12% -5% $184,604,131.62
CHM Chimeric Therapeutic 0.2625 3% 1% -28% 0% $59,501,874.78
MX1 Micro-X Limited 0.2675 3% -8% -20% -31% $121,933,852.43
GLH Global Health Ltd 0.36 3% -10% -31% -23% $19,813,287.20
CAJ Capitol Health 0.38 3% 6% 1% 38% $416,887,004.80
ALA Arovella Therapeutic 0.038 3% 9% -43% -5% $19,236,835.20
M7T Mach7 Tech Limited 0.83 2% -5% -21% -31% $196,947,421.50
CYC Cyclopharm Limited 1.665 2% -5% -2% -36% $153,134,709.72
ONE Oneview Healthcare 0.255 2% 16% -45% 454% $134,264,341.38
ALC Alcidion Group Ltd 0.27 2% -19% -27% 45% $342,378,644.31
VBS Vectus Biosystems 1.41 2% 13% 8% 18% $45,891,903.09
AN1 Anagenics Limited 0.058 2% 2% -8% -46% $12,772,611.81
RCE Recce Pharmaceutical 1.0175 2% 16% 4% -6% $179,001,482.41
SHG Singular Health 0.295 2% -2% -6% 0% $17,790,707.55
IMM Immutep Ltd 0.505 1% 9% -7% 22% $431,332,014.51
ALT Analytica Limited 0.002 0% 0% 0% -20% $9,227,602.26
AMT Allegra Orthopaedics 0.15 0% -6% -23% -54% $15,668,880.45
ACR Acrux Limited 0.1 0% -9% -31% -39% $28,368,033.80
TRP Tissue Repair 0.55 0% -2% 0% 0% $21,720,007.08
HXL Hexima 0.4 0% 0% 150% 122% $64,905,936.83
SCU Stemcell United Ltd 0.014 0% 0% -18% -18% $14,606,489.21
IPD Impedimed Limited 0.175 0% 6% 59% 46% $301,888,125.34
ICS ICSGlobal Limited 0.575313 0% 0% 0% 6% $6,054,604.94
AHC Austco Healthcare 0.15 0% 11% 30% 52% $41,207,397.90
AGH Althea Group 0.23 0% -6% -35% -48% $70,296,980.18
PIQ Proteomics Int Lab 1.14 0% -1% 23% 46% $120,447,697.50
BNO Bionomics Limited 0.105 0% -19% -46% -22% $144,051,241.84
NC6 Nanollose Limited 0.1 0% 0% 12% 72% $14,888,636.80
NTI Neurotech Intl 0.058 0% 2% 9% 38% $40,438,477.31
OIL Optiscan Imaging 0.17 0% -8% -24% 48% $108,357,480.35
SDI SDI Limited 1.01 0% -4% 13% 31% $120,054,185.30
S66 Star Combo 0.255 0% -4% 0% -23% $34,298,260.16
BPH BPH Energy Ltd 0.037 0% -3% -53% -10% $24,602,017.39
PAL Palla Pharma Ltd 0.295 0% -24% -25% -61% $47,764,383.09
OSP Osprey Med Inc 0.575 0% -20% -62% -73% $14,753,661.65
LCT Living Cell Tech. 0.006 0% -14% -63% -55% $5,656,000.48
RAC Race Oncology Ltd 3.52 0% 7% -3% 81% $581,973,454.30
ARX Aroa Biosurgery 1.015 0% -9% -10% -11% $347,430,575.00
OPT Opthea Limited 1.3175 -1% 19% 3% -32% $473,358,331.60
VHT Volpara Health Tech 1.01 -1% -7% -17% -28% $262,776,829.65
OVN Oventus Medical Ltd 0.084 -1% -6% -10% -60% $20,788,482.01
1AD Adalta Limited 0.081 -1% -1% -42% -37% $24,800,736.30
ZNO Zoono Group Ltd 0.37 -1% -1% -45% -72% $61,165,701.59
VLS Vita Life Sciences.. 1.895 -2% 11% 69% 90% $95,827,753.84
PCK Painchek Ltd 0.053 -2% -7% -15% -32% $58,853,849.55
MVF Monash IVF Group Ltd 1.045 -2% 15% 23% 32% $411,064,756.20
OCC Orthocell Limited 0.5 -2% -4% -17% 2% $99,549,596.07
MEM Memphasys Ltd 0.088 -2% -4% 28% -30% $74,068,674.51
ATH Alterity Therap Ltd 0.0205 -2% -11% -47% -34% $48,137,491.56
CAN Cann Group Ltd 0.2875 -3% -4% -32% -52% $101,167,805.87
EXL Elixinol Wellness 0.072 -3% -12% -45% -59% $23,377,427.02
MVP Medical Developments 5.08 -3% 3% 10% -23% $359,964,287.85
PNV Polynovo Limited 1.51 -3% 7% -44% -62% $1,031,765,348.64
ATX Amplia Therapeutics 0.16 -3% -9% -28% -33% $31,016,640.16
PAR Paradigm Bio. 1.89 -3% -3% -9% -23% $432,432,010.50
BXN Bioxyne Ltd 0.025 -4% 9% 0% 127% $18,564,216.54
IMU Imugene Limited 0.3975 -4% -22% 9% 298% $2,450,364,748.45
ICR Intelicare Holdings 0.086 -4% 0% -53% -65% $7,774,223.76
AC8 Auscann Grp Hlgs Ltd 0.081 -5% -2% -26% -58% $35,684,315.91
IMC Immuron Limited 0.1 -5% -9% -38% -53% $22,779,834.60
RHY Rhythm Biosciences 1.48 -5% -8% 65% 31% $319,686,260.04
BWX BWX Limited 4.405 -5% 4% -13% 6% $703,081,097.51
IDT IDT Australia Ltd 0.265 -5% -49% -21% 41% $62,363,644.20
EZZ EZZ Life Science 0.51 -6% 12% 15% 0% $6,571,400.00
AVE Avecho Biotech Ltd 0.015 -6% 0% -17% -44% $27,541,747.89
HCT Holista CollTech Ltd 0.043 -7% -16% -26% -40% $12,666,058.00
HGV Hygrovest Limited 0.057 -7% -15% -36% -56% $13,107,377.15
PYC PYC Therapeutics 0.13 -7% -7% -13% -13% $413,520,393.39
1ST 1St Group Ltd 0.013 -7% 0% -36% -61% $6,800,975.01
JTL Jayex Technology Ltd 0.019 -10% -10% -30% -53% $4,735,342.24
EPN Epsilon Healthcare 0.069 -10% -34% -49% -72% $15,812,193.38
TSN The Sust Nutri Grp 0.185 -16% -21% -51% -47% $23,518,245.08
GTG Genetic Technologies 0.005 -17% -17% -44% -38% $46,169,825.72

 

BIGGEST WINNERS

The biggest winner this week is health-care tech and services company Resonance Health (ASX:RHT) with no news but on December 30 it announced that clearance had been received from the US Food & Drug Administration for the commercial sale of its LiverSmart AI medical device.

Like RHT, Lumos Diagnostics (ASX:LDX) is up 51% for no real reason while LBT Innovations (ASX:LBT) is still relishing in the fact that it has completed the acquisition of Hettich Holding Beteiligungs-und Verwaltungs-GmbH’s (Hettich) with a 50% shareholding of its Clever Culture Systems joint venture (CCS). This means CSS will become a fully owned subsidiary of LBT with no outstanding debt owing to Hettich.

Third biggest winner this week is Atomo Diagnostics (ASX:AT1) – a company that provides rapid testing products and benefits from COVID testing.

But perhaps the only biotech stock to rock the boat with some real news is cancer fighter Noxopharm (ASX:NOX), which climbed 11% yesterday after revealing the appointment of new CEO Dr Gisela Mautner. NOX said at the time this change reflected the company’s transition from an early-stage biotech business into a serious bio-pharma play.

Earlier in December, Noxopharm announced it had completed the enrolment of the first dose cohort of patients in its DARRT-2 phase-2 clinical trial. DAART-2 is an immunotherpapy cancer treatment, designed to trigger an immune response in a single tumour, resulting in tumours in the rest of the body resolving despite not receiving any radiation.

DARRT-2 is being undertaken across multiple sites in North America, Europe, and Australia involving approximately 100 patients with metastatic cancers (prostate, breast, lung) who are eligible for low-dose radiotherapy.

Winners share price charts

 

 

 

BIGGEST LOSERS

This week’s biggest dipper is Genetic Technologies (ASX:GTG), despite having announced “momentum was building” with cash receipts gaining 112% to A$1.8m on December 21.

GTG said its focus in the coming quarters include will be on leveraging its acquisition of EasyDNA by including the Multi-Test product, where it expects to see solid growth in revenue across all brands and products as these initiatives are rolled out.

The diversified modular diagnostics company has continued to expand and develop its geneType COVID-19 Risk Test, having recently completed a crossvalidation study on a European data set confirming the test performance metrics.

A paper describing the study has now been submitted to a peer-reviewed journal and will be released upon publication

The Sustainable Nutrition Group (ASX:TSN) is the second biggest loser, dropping -16% and in third place is Jayex Technology (ASX:JTL) – a leading providing in the UK and Australia of integrated healthcare services, losing it by -10%.

Other losers this past week include Hygrovest (ASX:HGV), formerly MMJ Group Holdings (ASX:MMJ), Epsilon Healthcare (ASX:EPN), Rhythm Biosciences (ASX:RHY), Bioxyne (ASX:BXN), and Avecho Biotech (ASX:AVE).

At the end of December, AVE unveiled it had entered into a licensing and supply agreement with Medterra Pharma – one of the most successful CBD companies in the United States known for developing and selling science-backed products.

Medterra will develop Avecho’s CBD soft-gel capsule product as an oral treatment for arthritis indications including osteoarthritis and rheumatoid arthritis. Scientits have already demonstrated the therapeutic potential of CBD for the treatment for arthritis in preclinical models.

The first human study using the CBD soft-gel in osteoarthritis already has Institutional Review Board approval with an Investigational New Drug Application (IND) to be submitted to the FDA this quarter.

This study will be a 6-week, randomized, double-blind placebo-controlled study exploring the therapeutic potential of the CBD soft-gel for reducint pain in patients with osteoarthritis of the knee, conducted at the Michael E. DeBakery Veterans Affairs Medical Center in Houston, Texas.

Losers share price charts